LHD: 2-[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]ethyl-[[4-azanyl-1-(methoxymethyl)-2-oxidanylidene-pyrimidin-5-yl]methyl]azanium
LHD is a Ligand Of Interest in 5TBJ designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5TBJ_LHD_C_501 | 67% | 68% | 0.078 | 0.918 | 0.26 | 0.78 | - | 1 | 0 | 0 | 100% | 1 |
| 5TBJ_LHD_A_501 | 60% | 67% | 0.088 | 0.902 | 0.26 | 0.82 | - | 1 | 1 | 0 | 100% | 1 |
| 5TBJ_LHD_D_501 | 55% | 70% | 0.097 | 0.892 | 0.27 | 0.72 | - | 1 | 0 | 0 | 100% | 1 |
| 5TBJ_LHD_B_501 | 49% | 51% | 0.106 | 0.879 | 0.3 | 1.44 | - | 3 | 1 | 0 | 100% | 1 |
